Quarterly Revenue
$20.50 K
+$8200.00+66.67%
September 30, 2024
Summary
- As of February 12, 2025, CTCX quarterly revenue is $20.50 thousand, with the most recent change of +$8200.00 (+66.67%) on September 30, 2024.
- Over the past year, CTCX quarterly revenue has dropped by -$3.71 million (-99.45%).
- CTCX quarterly revenue is now -99.45% below its all-time high of $3.73 million, reached on September 30, 2023.
Performance
CTCX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
-$3.70 M
-$3.71 M-30148.78%
September 30, 2024
Summary
- As of February 12, 2025, CTCX TTM revenue is -$3.70 million, with the most recent change of -$3.71 million (-30148.78%) on September 30, 2024.
- Over the past year, CTCX TTM revenue has dropped by -$7.42 million (-199.12%).
- CTCX TTM revenue is now -199.12% below its all-time high of $3.73 million, reached on September 30, 2023.
Performance
CTCX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
CTCX Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -99.5% | -199.1% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
CTCX Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -99.5% | +100.5% | -199.1% | at low | ||
| 5 y | 5-year | -99.5% | +100.5% | -199.1% | at low | ||
| alltime | all time | -99.5% | +100.5% | -199.1% | at low |
Carmell Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $20.50 K(+66.7%) | -$3.70 M(<-9900.0%) |
| Jun 2024 | - | $12.30 K(-100.3%) | $12.30 K(>+9900.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | - | -$3.73 M(-200.0%) | $0.00(-100.0%) |
| Sep 2023 | - | $3.73 M | $3.73 M |
FAQ
- What is Carmell Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Carmell Therapeutics?
- What is Carmell Therapeutics quarterly revenue year-on-year change?
- What is Carmell Therapeutics TTM revenue?
- What is the all time high TTM revenue for Carmell Therapeutics?
- What is Carmell Therapeutics TTM revenue year-on-year change?
What is Carmell Therapeutics quarterly revenue?
The current quarterly revenue of CTCX is $20.50 K
What is the all time high quarterly revenue for Carmell Therapeutics?
Carmell Therapeutics all-time high quarterly revenue is $3.73 M
What is Carmell Therapeutics quarterly revenue year-on-year change?
Over the past year, CTCX quarterly revenue has changed by -$3.71 M (-99.45%)
What is Carmell Therapeutics TTM revenue?
The current TTM revenue of CTCX is -$3.70 M
What is the all time high TTM revenue for Carmell Therapeutics?
Carmell Therapeutics all-time high TTM revenue is $3.73 M
What is Carmell Therapeutics TTM revenue year-on-year change?
Over the past year, CTCX TTM revenue has changed by -$7.42 M (-199.12%)